Your browser doesn't support javascript.
loading
Respiratory drive heterogeneity associated with systemic inflammation and vascular permeability in acute respiratory distress syndrome.
Baedorf-Kassis, Elias; Murn, Michael; Dzierba, Amy L; Serra, Alexis L; Garcia, Ivan; Minus, Emily; Padilla, Clarissa; Sarge, Todd; Goodspeed, Valerie M; Matthay, Michael A; Gong, Michelle N; Cook, Deborah; Loring, Stephen H; Talmor, Daniel; Beitler, Jeremy R.
Afiliação
  • Baedorf-Kassis E; Division of Pulmonary and Critical Care Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Murn M; Columbia Respiratory Critical Care Trials Group, Columbia University College of Physicians and Surgeons, and New York-Presbyterian Hospital, 622 West 168th Street, New York, NY, 10032, USA.
  • Dzierba AL; Center for Acute Respiratory Failure, New York-Presbyterian Hospital, New York, NY, USA.
  • Serra AL; Columbia Respiratory Critical Care Trials Group, Columbia University College of Physicians and Surgeons, and New York-Presbyterian Hospital, 622 West 168th Street, New York, NY, 10032, USA.
  • Garcia I; Center for Acute Respiratory Failure, New York-Presbyterian Hospital, New York, NY, USA.
  • Minus E; Department of Pharmacy, New York-Presbyterian Hospital, New York, NY, USA.
  • Padilla C; Columbia Respiratory Critical Care Trials Group, Columbia University College of Physicians and Surgeons, and New York-Presbyterian Hospital, 622 West 168th Street, New York, NY, 10032, USA.
  • Sarge T; Center for Acute Respiratory Failure, New York-Presbyterian Hospital, New York, NY, USA.
  • Goodspeed VM; Columbia Respiratory Critical Care Trials Group, Columbia University College of Physicians and Surgeons, and New York-Presbyterian Hospital, 622 West 168th Street, New York, NY, 10032, USA.
  • Matthay MA; Center for Acute Respiratory Failure, New York-Presbyterian Hospital, New York, NY, USA.
  • Gong MN; Departments of Medicine and Anesthesia, University of California San Francisco, San Francisco, CA, USA.
  • Cook D; Columbia Respiratory Critical Care Trials Group, Columbia University College of Physicians and Surgeons, and New York-Presbyterian Hospital, 622 West 168th Street, New York, NY, 10032, USA.
  • Loring SH; Center for Acute Respiratory Failure, New York-Presbyterian Hospital, New York, NY, USA.
  • Talmor D; Department of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Beitler JR; Department of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Crit Care ; 28(1): 136, 2024 04 23.
Article em En | MEDLINE | ID: mdl-38654391
ABSTRACT

BACKGROUND:

In acute respiratory distress syndrome (ARDS), respiratory drive often differs among patients with similar clinical characteristics. Readily observable factors like acid-base state, oxygenation, mechanics, and sedation depth do not fully explain drive heterogeneity. This study evaluated the relationship of systemic inflammation and vascular permeability markers with respiratory drive and clinical outcomes in ARDS.

METHODS:

ARDS patients enrolled in the multicenter EPVent-2 trial with requisite data and plasma biomarkers were included. Neuromuscular blockade recipients were excluded. Respiratory drive was measured as PES0.1, the change in esophageal pressure during the first 0.1 s of inspiratory effort. Plasma angiopoietin-2, interleukin-6, and interleukin-8 were measured concomitantly, and 60-day clinical outcomes evaluated.

RESULTS:

54.8% of 124 included patients had detectable respiratory drive (PES0.1 range of 0-5.1 cm H2O). Angiopoietin-2 and interleukin-8, but not interleukin-6, were associated with respiratory drive independently of acid-base, oxygenation, respiratory mechanics, and sedation depth. Sedation depth was not significantly associated with PES0.1 in an unadjusted model, or after adjusting for mechanics and chemoreceptor input. However, upon adding angiopoietin-2, interleukin-6, or interleukin-8 to models, lighter sedation was significantly associated with higher PES0.1. Risk of death was less with moderate drive (PES0.1 of 0.5-2.9 cm H2O) compared to either lower drive (hazard ratio 1.58, 95% CI 0.82-3.05) or higher drive (2.63, 95% CI 1.21-5.70) (p = 0.049).

CONCLUSIONS:

Among patients with ARDS, systemic inflammatory and vascular permeability markers were independently associated with higher respiratory drive. The heterogeneous response of respiratory drive to varying sedation depth may be explained in part by differences in inflammation and vascular permeability.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome do Desconforto Respiratório / Permeabilidade Capilar / Biomarcadores / Inflamação Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome do Desconforto Respiratório / Permeabilidade Capilar / Biomarcadores / Inflamação Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article